Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe new version removes the government funding operating-status notice that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedThe old and new screenshots display the same list of study record versions with no additional status changes or essential data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference11%

- Check98 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.